Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease | Presented at the European Hematology Association (EHA) Annual Congressnews2024-06-14T09:10:47+00:00June 14th, 2024|Medical Device News Magazine|
